![Jonathan Haug](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Jonathan R.
Haug is currently Chief Executive Officer at ARMO Biosciences, Inc. and DICE Therapeutics, Inc. He is President & Director at Ventyx Biosciences, Inc. starting in 2026, President & Director at Morphic Holding, Inc., President & Director at Adverum Biotechnologies, Inc. starting in 2025, President & Director at Scorpion Therapeutics, Inc., and President at Verve Therapeutics, Inc. starting in 2025.
Formerly, Mr. Haug was Chief Executive Officer at Prevail Therapeutics, Inc.
Jonathan Haug active positions
| Companies | Position | Start |
|---|---|---|
| VERE THER | President | 2025-07-24 |
| ADVERUM BIOTECHNOLOGIES, INC. | President | 2025-12-08 |
| VENTYX BIOSCIENCES, INC. | President | 2026-03-03 |
| MORC HOLD | President | - |
| ARMO BIOSCIENCES INC | Chief Executive Officer | - |
| DICE THER | Chief Executive Officer | - |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | President | - |
Former positions of Jonathan Haug
| Companies | Position | End |
|---|---|---|
| PREVAIL THERAPEUTICS INC. | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Jonathan Haug
